You have 9 free searches left this month | for more free features.

dacarbazine

Showing 1 - 25 of 113

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hodgkin Lymphoma Trial in Houston (Brentuximab vedotin, Doxorubicin Hydrochloride, Pembrolizumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • Brentuximab vedotin
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 20, 2023

LMS - Leiomyosarcoma, Uterine Leiomyosarcoma Trial in Stanford (drug, procedure, behavioral)

Suspended
  • LMS - Leiomyosarcoma
  • Uterine Leiomyosarcoma
  • Stanford, California
    Stanford University
Oct 24, 2022

Classical Hodgkin Lymphoma Trial in Seattle (drug, other, biological)

Recruiting
  • Classical Hodgkin Lymphoma
  • Dacarbazine
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2022

Metastatic Uveal Melanoma Trial in Grand Rapids (IDE196, Crizotinib, Pembrolizumab)

Recruiting
  • Metastatic Uveal Melanoma
  • Grand Rapids, Michigan
    The Cancer and Hematology Centers
Aug 14, 2023

Hodgkin Disease Trial in Worldwide (Brentuximab vedotin, Doxorubicin, Vinblastine)

Completed
  • Hodgkin Disease
  • Brentuximab vedotin
  • +3 more
  • Aurora, Colorado
  • +13 more
Jun 17, 2022

Solitary Fibrous Tumors Trial in Italy (Trabectedin, Adriamycin, Dacarbazine)

Recruiting
  • Solitary Fibrous Tumors
  • Prato, Firenze, Italy
  • +5 more
Oct 29, 2021

Classical Hodgkin Lymphoma Trial in Cologne (Nivolumab, Adriamycin, Vinblastine)

Active, not recruiting
  • Classical Hodgkin Lymphoma
  • Cologne, Germany
    University Hospital of Cologne
Aug 5, 2022

Classical Hodgkin Lymphoma Trial in Charlottesville (Pembrolizumab, Doxorubicin, Vinblastine)

Recruiting
  • Classical Hodgkin Lymphoma
  • Charlottesville, Virginia
    University of Virginia
Jul 27, 2022

Malignant Melanoma, Recurrent Melanoma Trial (Dacarbazine, Fotemustine, Interferon Alfa-2b)

Completed
  • Malignant Melanoma
  • Recurrent Melanoma
  • Dacarbazine
  • +2 more
  • (no location specified)
Oct 18, 2020

HIV Infection, HIV-associated Hodgkin Lymphoma, Stage III Adult Hodgkin Lymphoma Trial in France (brentuximab vedotin,

Active, not recruiting
  • HIV Infection
  • +3 more
  • brentuximab vedotin
  • +3 more
  • Clamart, France
  • +5 more
Aug 11, 2022

Breast Cancer, Breast Tumors, Colon Cancer Trial in United States (AZD6244, Dacarbazine, Erlotinib)

Active, not recruiting
  • Breast Cancer
  • +7 more
  • Detroit, Michigan
  • +3 more
Dec 22, 2022

Hodgkin Lymphoma Trial in United Kingdom (Involved site radiotherapy, Doxorubicin, Bleomycin)

Recruiting
  • Hodgkin Lymphoma
  • Involved site radiotherapy
  • +6 more
  • Aberdeen, United Kingdom
  • +6 more
May 24, 2022

Melanoma Trial in Germany (PTK787/ZK 222584, Dacarbazine)

Terminated
  • Melanoma
  • PTK787/ZK 222584
  • Dacarbazine
  • Essen, Germany
  • +3 more
Sep 28, 2021

Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma Trial in Worldwide (AL3818, Dacarbazine, AL3818 or )

Active, not recruiting
  • Alveolar Soft Part Sarcoma
  • +3 more
  • Phoenix, Arizona
  • +22 more
Nov 1, 2022

Classical Hodgkin Lymphoma Trial in Zhengzhou (Camrelizumab, Epirubicin, Vincristine)

Recruiting
  • Classical Hodgkin Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Dec 29, 2020

Soft Tissue Sarcoma Trial in Münster (Dacarbazine, onfekafusp alfa)

Recruiting
  • Soft Tissue Sarcoma
  • Dacarbazine
  • onfekafusp alfa
  • Bordeaux, France
  • +15 more
Dec 22, 2022

HIV, Hodgkin's Disease Trial in United States (Vinblastine sulfate, Dacarbazine, Filgrastim)

Completed
  • HIV Infections
  • Hodgkin's Disease
  • Vinblastine sulfate
  • +4 more
  • Birmingham, Alabama
  • +7 more
Oct 26, 2021

Soft Tissue Sarcoma, Bone Sarcoma Trial in Italy, Spain, United Kingdom (Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent], Nivolumab

Recruiting
  • Soft Tissue Sarcoma
  • Bone Sarcoma
  • Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent]
  • +7 more
  • Bologna, Italy
  • +12 more
Nov 10, 2021

Hodgkin Lymphoma, Adult Trial in Moscow (Doxorubicin, Bleomycin, Vinblastine)

Recruiting
  • Hodgkin Lymphoma, Adult
  • Moscow, Russian Federation
    The Federal Budget-Funded Institution National Medical Surgical
Nov 20, 2020

AIDS-Related Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in France, United

Active, not recruiting
  • AIDS-Related Hodgkin Lymphoma
  • +11 more
  • Brentuximab Vedotin
  • +4 more
  • La Jolla, California
  • +27 more
Jul 27, 2022

Hodgkin Lymphoma Trial in Canada, United States (doxorubicin, Bleomycin, vinblastine)

Recruiting
  • Hodgkin Lymphoma
  • Detroit, Michigan
  • +9 more
Feb 16, 2022

Melanoma Trial in Canada, United States (rIL-21, Dacarbazine)

Completed
  • Melanoma
  • Los Angeles, California
  • +18 more
Dec 8, 2020

Melanoma Trial in China (Ipilimumab, Dacarbazine)

Completed
  • Melanoma
  • Nanjing, Jiangsu, China
  • +7 more
May 5, 2020

Stage IV Melanoma Trial in Cleveland (recombinant interferon alfa-2b, cisplatin, sodium stibogluconate)

Completed
  • Stage IV Melanoma
  • recombinant interferon alfa-2b
  • +4 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Institute, Case Comprehensive Cancer Ce
Jul 22, 2020

Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)

Not yet recruiting
  • Classic Hodgkin Lymphoma
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Jan 6, 2023